What is the Share Price of Indrayani Biotech Ltd?

Indrayani Biotech Ltd share price is ₹16.62 As on 09 May, 2025|14:41

Home
>
Stocks
>
Indrayani Biotech Ltd

Indrayani Biotech Ltd Share Price

Q: What is the Market Cap of Indrayani Biotech Ltd?

The Market Cap of Indrayani Biotech Ltd is ₹77.2 As on 09 May, 2025|14:41

Q: What is PE Ratio of Indrayani Biotech Ltd?

The P/E ratio of Indrayani Biotech Ltd is 188 As on 09 May, 2025|14:41

Q: What is PB Ratio of Indrayani Biotech Ltd?

The PB ratio of Indrayani Biotech Ltd is 16.14 As on 09 May, 2025|14:41

₹ 0.00 0 (0%)
Updated on 01-01-1970 5:30 AM

Stock Rating

BSE

Pros 1

Cons 8

Indrayani Biotech Ltd Price Performance

Day's Low
₹0

Day's High
₹0

₹ 0

52-w low
₹0

52-w high
₹0

Day's open
₹0
Previous close
₹0
VWAP
₹0
Lower price band
₹0
Upper price band
₹0

Today's Market Action

Its last traded stock price on BSE was 16.62 down by -1.95%. The total volume of shares on NSE and BSE combined was 445 shares. Its total combined turnover was Rs 0.00 crores.

Indrayani Biotech Ltd Medium and Long Term Market Action

The stock price of Indrayani Biotech Ltd is down by -100% over the last one month. Don't forget to check the full stock price history in the table below.

Indrayani Biotech Ltd Fundamentals

Market Cap (Cr): 77.2
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Indrayani Biotech Ltd Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Indrayani Biotech Ltd Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Indrayani Biotech Ltd

Data not available.

Indrayani Biotech Ltd FAQ's

What is Share Price of Indrayani Biotech Ltd?

What is the Market Cap of Indrayani Biotech Ltd?

What is PE Ratio of Indrayani Biotech Ltd?

What is PB Ratio of Indrayani Biotech Ltd?

What is the CAGR of Indrayani Biotech Ltd?

How to Buy Indrayani Biotech Ltd Share?

Can I buy Indrayani Biotech Ltd from Samco?

How do I buy Indrayani Biotech Ltd from Samco?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

Great Cash Conversion of Profits
The business has a great cash conversion ratio since it is able to convert a signifant portion of operating earnings of 276.96% into operating cash flow. This implies a great working capital cycle and large cash flows for either funding growth or dividends. This shall positively impact shareholder returns.

Cons

Low Sustainable RoE
The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Low Interest Coverage
The company has a very low Interest coverage ratio of 1.17 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
Low Pricing Power & High Competition
The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
Capital Intensive Business
The company operates an extremely capital intensive business with a low Asset turnover ratio of 1.71. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
Poor Working Capital Cycle
The company has a very poor working capital cycle of 129 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
Poor Corporate Governance
The general corporate governance standards of the company are poor which can negatively impact shareholder value and returns.
High Promoter Pledge
The company has a relatively high promoter pledge to the extent of 25% of the total company's shareholding which can have a significantly negative impact on stock.

Valuation Analysis

Margin of safety
(09/05/2025)

Margin of Safety Index: High

71.43%

71.43% People are bullish about Indrayani Biotech Ltd

28.57%

28.57 % People are bearish about Indrayani Biotech Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %